E-LIB Suche - Ergebnisse für: Papia, Francesco

1

Sustained remission induced by 2 years of treatment with be..:

Pelaia, Corrado ; Crimi, Claudia ; Benfante, Alida...
Respirology. , 2024

Link: https://doi.org/10.1111/..

2

Benralizumab in Patients with Severe Eosinophilic Asthma: A..:

Scioscia, Giulia ; Tondo, Pasquale ; Nolasco, Santi...
Journal of Clinical Medicine. 12 (2023) 13 - p. 4362 , 2023

Link: https://doi.org/10.3390/..

3

Real-world characteristics of "super-responders" to mepoliz..:

Portacci, Andrea ; Campisi, Raffaele ; Buonamico, Enrico...
ERJ Open Research. 9 (2023) 5 - p. 00419-2023 , 2023

Link: https://doi.org/10.1183/..

4

Real-life effects of dupilumab in patients with severe type..:

Pelaia, Corrado ; Benfante, Alida ; Busceti, Maria Teresa...
Frontiers in Immunology. 14 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

5

Effectiveness and safety of anti-IL-5/Rα biologics in eosin..:

Nolasco, Santi ; Portacci, Andrea ; Campisi, Raffaele...
Frontiers in Immunology. 14 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

6

Omalizumab in middle-aged or older patients with severealle..:

Ricciardi, Luisa ; Papia, Francesco ; Liotta, Marta...
Advances in Dermatology and Allergology. 39 (2022) 1 - p. 88-93 , 2022

Link: https://doi.org/10.5114/..

7

Exploring Machine Learning Techniques to Predict the Respon..:

Sardina, Davide Stefano ; Valenti, Giuseppe ; Papia, Francesco.
Diagnostics. 11 (2021) 11 - p. 2150 , 2021

Link: https://doi.org/10.3390/..

8

Hymenoptera sting reactions in southern Italy forestry work..:

Ricciardi, Luisa ; Papia, Francesco ; Cataldo, Giuseppe...
Clinical and Molecular Allergy. 16 (2018) 1 - p. , 2018

Link: https://doi.org/10.1186/..

9

Real-life effects of dupilumab in patients with severe type..:

Corrado Pelaia ; Alida Benfante ; Maria Teresa Busceti...
https://www.frontiersin.org/articles/10.3389/fimmu.2023.1121237/full. , 2023

Link: https://doi.org/10.3389/..

10

Benralizumab in Patients with Severe Eosinophilic Asthma: A..:

Giulia Scioscia ; Pasquale Tondo ; Santi Nolasco...
https://www.mdpi.com/2077-0383/12/13/4362. , 2023

Link: https://doi.org/10.3390/..

11

Benralizumab in Patients with Severe Eosinophilic Asthma: A..:

Giulia Scioscia ; Pasquale Tondo ; Santi Nolasco...
Pulmonology. , 2023

Link: https://doi.org/10.3390/..

12

Effectiveness and safety of anti-IL-5/Rα biologics in eosin..:

Santi Nolasco ; Andrea Portacci ; Raffaele Campisi...
https://www.frontiersin.org/articles/10.3389/fimmu.2023.1204444/full. , 2023

Link: https://doi.org/10.3389/..

13

Real-world characteristics of "super-responders" to mepoliz..:

Andrea Portacci ; Raffaele Campisi ; Enrico Buonamico...
http://openres.ersjournals.com/content/9/5/00419-2023.full. , 2023

Link: https://doi.org/10.1183/..

14

DataSheet_1_Effectiveness and safety of anti-IL-5/Rα biolog..:

Santi Nolasco ; Andrea Portacci ; Raffaele Campisi...
doi:10.3389/fimmu.2023.1204444.s001. , 2023

Link: https://doi.org/10.3389/..

15

Omalizumab in middle-aged or older patients with severe all..:

Luisa Ricciardi ; Francesco Papia ; Marta Liotta...
https://www.termedia.pl/Omalizumab-in-middle-aged-or-older-patients-with-severe-r-nallergic-asthma-COPD-overlap,7,46465,1,1.html. , 2022

Link: https://doi.org/10.5114/..